Palatin Appeals NYSE American Notice of Delisting
Palatin Technologies, Inc. (the “Company”) (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, announced today that...
